Clinical Trials Directory

Trials / Completed

CompletedNCT03599219

Platelet Dysfunction in Blood Donors

Prevalence of Platelet Dysfunction Inblood With a Bleeding History

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
1,500 (actual)
Sponsor
Etablissement Français du Sang · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

Platelets are circulating blood cells. They bind to each other and to the damaged vessel wall to prevent excessive bllod loss. Unlike quantitative platelet defects, there is no automated, simple test to diagnose qualitative platelets defects. However, these defects expose to bleeding in a surgical situation and could explain the transfusion inefficiency of some platelet concentrates. In recent decades, considerable progress has been made in understanding qualitative platelet disorders. In this project, we propose to submit blood donors to a standardized hemorrhagic diathesis questionnaire and to compare the prevalence of platelet function abnormalities in blood donors with and without hemorrhagic diathesis.

Detailed description

Primary objective specify the prevalence of qualitative platelet disorders in blood donors with i) a clinical history of bleeding diathesis collected through a standardized and validated questionnaire ii) and / or a hematoma (more than 4 cm) that occurred during blood donation. Secondary objectives to obtain the prevalence of other defects of hemostasis

Conditions

Interventions

TypeNameDescription
BIOLOGICALsampleconfirmation of platelet dysfunction

Timeline

Start date
2017-07-10
Primary completion
2019-06-07
Completion
2019-06-07
First posted
2018-07-26
Last updated
2024-01-31

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03599219. Inclusion in this directory is not an endorsement.